What's breaking now, across thousands of outlets.
OXFORD, England — Making rare disease treatments economically attractive for drugmakers requires looking outside rare disease, according to experts interviewed by Endpoints News. The pharmaceutical industry’s lack of investment in ultra-rare diseases came up time ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- The FDA recently approved a new flu vaccine that tested well in older adults. But the federal agency responsible for telling doctors and the general public how to use it has made no…
A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease.
The Council of Governors is seeking global partnerships to finance a Ksh68.8 billion investment plan aimed at reducing preventable maternal and newborn deaths across Kenya’s 47 counties.
In a Canadian first, the cardiac team from London Health Sciences Centre (LHSC) has completed a heart transplant using the Transmedics Organ Care system, often referred to as “heart in a box.” The…
The findings add new fodder for critics who say 340B has ballooned out of control with no corresponding benefit to patients.
